1 / 10

Global Mycoplasma Testing Market Size, Growth | Industry Report, 2025

Mycoplasma Testing Market Analysis By Product, By Technology (PCR, ELISA, Direct Assay, Microbial Culture Techniques), By Application (Cell Line, Virus, & End of Production Cells Testing), By End-use, And Segment Forecasts, 2018 - 2025

Marsh
Télécharger la présentation

Global Mycoplasma Testing Market Size, Growth | Industry Report, 2025

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Mycoplasma Testing Market Analysis, Size, Growth, Share & Forecast to 2025 | Grand View Research Inc. “Mycoplasma Testing Market Worth $1.4 Billion By 2025 | CAGR: 14.1%.” The global Mycoplasma Testing Market is expected to reach a value of USD 1.4 billion by 2025, according to a new report by Grand View Research, Inc. With growing R&D investments in the field of life sciences, the demand for mycoplasma testing products are anticipated to rise in the near future. Huge opportunities in the life sciences segment are spurring the market growth. Hence, a large amount of investment is being made in the biotechnology and pharmaceutical industries with rising level of healthcare spending across the globe. This is expected to trigger high growth of mycoplasma testing market. Investment in R&D activities by pharmaceutical and biotechnology companies is increasingly being supported by the government. Researches involving drug discovery and development, receive funding from the governmental bodies to a great extent. Moreover, governmental initiatives in the form of awareness campaigns for chronic diseases such as cancer are also encouraging research-based activities. Thus, the aforementioned factors are expected to drive the market growth. Mycoplasma contamination of cell culture is a growing concern for most of the research scientists for decades. Mycoplasma infection arises majorly from laboratory workers as human mycoplasma contamination occurs at a faster rate. In order to combat further contamination, mycoplasma tests are being conducted, which is expected to increase the demand of the related products. Further Key Findings From the Study Suggest: In 2016, kits & reagents dominated the market and is also expected to show highest CAGR over the forecast period owing to its wider application in mycoplasma tests • Follow Us:

  2. Amongst the technology segment, Polymerase Chain Reaction (PCR) held the largest share in 2016 owing to the delivery of fast & accurate results associated with this technology • Cell line testing is anticipated to exhibit highest CAGR over the forecast period due to the increasing risk of cell line contamination • In 2016, pharmaceutical and biotechnology companies accounted for the largest market share due to rising number of research activities in drug discovery and development • North America dominated the market in 2016 owing to rising healthcare spending levels and government funding for life science-related research • Some of the key players are Merck KGaA; Sigma-Aldrich Co.; Thermo Fisher Scientific; Lonza Group Ltd.; Charles River Laboratories International, Inc.; PromoCell GmbH; and Bionique Testing Laboratories, Inc. • Browse Details of Report @ http://www.grandviewresearch.com/industry-analysis/mycoplasma-testing- market Grand View Research has segmented the mycoplasma testing market on the basis of product, technology, application, end-use, and region: Mycoplasma Testing Product Outlook (Revenue, USD Million, 2014 - 2025) Instruments • Kits & Reagents • oPCR Assays oNucleic Acid Detection Kits oStains oElimination Kits oStandards & Controls oOthers Services • Mycoplasma Testing Technology Outlook (Revenue, USD Million, 2014 - 2025) PCR • ELISA • Direct Assay • Indirect Assay • Follow Us:

  3. Microbial Culture Techniques • Enzymatic Methods • Mycoplasma Testing Application Outlook (Revenue, USD Million, 2014 - 2025) Cell Line Testing • Virus Testing • End of Production Cells Testing • Others • Mycoplasma Testing End-Use Outlook (Revenue, USD Million, 2014 - 2025) Academic Research Institutes • Cell Banks • Contract Research Organizations • Pharmaceutical & Biotechnology Companies • Others • Mycoplasma Testing Regional Outlook (Revenue, USD Million, 2014 - 2025) North America • oU.S. oCanada Europe • oGermany oUK Asia Pacific • oJapan oChina oIndia Latin America • oBrazil Follow Us:

  4. oMexico MEA • oSouth Africa Table of Content Chapter 1 Research Methodology 1.1 Country Wise Market: Base Estimates 1.2 Global Market: CAGR Calculation 1.3 Region Based Segment Share Calculation 1.4 Research Scope & Assumptions 1.5 List of Data Sources 1.5.1 Data for primary interviews, by sources 1.5.2 Data for primary interviews, by region Chapter 2 Executive Summary 2.1 Market Snapshot Chapter 3 Mycoplasma Testing Market Variables, Trends & Scope 3.1 Market Segmentation & Scope 3.2 Market Driver Analysis 3.2.1 Increasing R&D investments in life sciences 3.2.2 Rising government support towards pharmaceutical and biotechnology industries 3.2.3 Rising cell culture contamination 3.3 Market Restraint Analysis 3.3.1 High cost of research in cell biology 3.4 Key Opportunities Prioritized 3.4.1 Key opportunities prioritized, by product 3.4.2 Key opportunities prioritized, by technology 3.4.3 Key opportunities prioritized, by application 3.4.4 Key opportunities prioritized, by end-use 3.5 Mycoplasma Testing - SWOT Analysis, By Factor (Political & Legal, Economic And Technological) 3.6 Industry Analysis - Porter’s 3.7 Competitive Landscape: Market Position Analysis, 2016 Chapter 4 Mycoplasma Testing: Product Estimates & Trend Analysis Follow Us:

  5. 4.1 Mycoplasma Testing Market: Product Movement Analysis 4.2 Instruments 4.2.1 Instruments market estimate & forecast, 2014 - 2025 (USD Million) 4.3 Kits & Reagents 4.3.1 Kits & reagents market estimate & forecast, 2014 - 2025 (USD Million) 4.3.2 PCR Assays 4.3.2.1 PCR assays market estimate & forecast, 2014 - 2025 (USD Million) 4.3.3 Nucleic Acid Detection Kits 4.3.3.1 Nucleic acid detection kits market estimate & forecast, 2014 - 2025 (USD Million) 4.3.4 Stains 4.3.4.1 Stains market estimate & forecast, 2014 - 2025 (USD Million) 4.3.5 Standards & Controls 4.3.5.1 Standards & controls market estimate & forecast, 2014 - 2025 (USD Million) 4.3.6 Others 4.3.6.1 Others market estimate & forecast, 2014 - 2025 (USD Million) 4.4 Services 4.4.1 Services market estimate & forecast, 2014 - 2025 (USD Million) Chapter 5 Mycoplasma Testing: Technology Estimates & Trend Analysis 5.1 Mycoplasma Testing market: Technology movement analysis 5.2 PCR 5.2.1 PCR market estimate & forecast, 2014 - 2025 (USD Million) 5.3 ELISA 5.3.1 ELISA market estimate & forecast, 2014 - 2025 (USD Million) 5.4 Direct Assay 5.4.1 Direct assay market estimate & forecast, 2014 - 2025 (USD Million) 5.5 Indirect Assay 5.5.1 Indirect assay market estimate & forecast, 2014 - 2025 (USD Million) 5.6 Microbial Culture Techniques 5.6.1 Microbial culture techniques market estimate & forecast, 2014 - 2025 (USD Million) 5.7 Enzymatic Methods 5.7.1 Enzymatic methods market estimate & forecast, 2014 - 2025 (USD Million) Chapter 6 Mycoplasma Testing: Application Estimates & Trend Analysis 6.1 Mycoplasma Testing Market: Application Movement Analysis 6.2 Cell Line Testing Follow Us:

  6. 6.2.1 Cell line testing market estimate & forecast, 2014 - 2025 (USD Million) 6.3 Virus Testing 6.3.1 Virus testing market estimate & forecast, 2014 - 2025 (USD Million) 6.4 End of Production Cells Testing 6.4.1 End of production cells testing market estimate & forecast, 2014 - 2025 (USD Million) 6.5 Others 6.5.1 Others market estimate & forecast, 2014 - 2025 (USD Million) Chapter 7 Mycoplasma Testing: End-Use Estimates & Trend Analysis 7.1 Mycoplasma Testing Market: End-Use Movement Analysis 7.2 Academic Research Institutes 7.2.1 Academic research institutes market estimate & forecast, 2014 - 2025 (USD Million) 7.3 Cell Banks 7.3.1 Cell banks market estimate & forecast, 2014 - 2025 (USD Million) 7.4 Contract Research Organizations 7.4.1 Contract research organizations market estimate & forecast, 2014 - 2025 (USD Million) 7.5 Pharmaceutical & Biotechnology Companies 7.5.1 Pharmaceutical & biotechnology companies market estimate & forecast, 2014 - 2025 (USD Million) 7.6 Others 7.6.1 Others market estimate & forecast, 2014 - 2025 (USD Million) Chapter 8 Mycoplasma Testing Market: Regional Estimates & Trend Analysis, by Product, Technology, Application, End-Use 8.1 Mycoplasma testing market share by region, 2017 & 2025 8.2 North America 8.2.1 U.S. 8.2.1.1 U.S. mycoplasma testing market, by product, 2014 - 2025 (USD Million) 8.2.1.2 U.S. mycoplasma testing market, by technology, 2014 - 2025 (USD Million) 8.2.1.3 U.S. mycoplasma testing market, by application, 2014 - 2025 (USD Million) 8.2.1.4 U.S. mycoplasma testing market, by end-use, 2014 - 2025 (USD Million) 8.2.2 Canada 8.2.2.1 Canada mycoplasma testing market, by product, 2014 - 2025 (USD Million) 8.2.2.2 Canada mycoplasma testing market, by technology, 2014 - 2025 (USD Million) 8.2.2.3 Canada mycoplasma testing market, by application, 2014 - 2025 (USD Million) 8.2.2.4 Canada mycoplasma testing market, by end-use, 2014 - 2025 (USD Million) Follow Us:

  7. 8.3 Europe 8.3.1 Germany 8.3.1.1 Germany mycoplasma testing market, by product, 2014 - 2025 (USD Million) 8.3.1.2 Germany mycoplasma testing market, by technology, 2014 - 2025 (USD Million) 8.3.1.3 Germany mycoplasma testing market, by application, 2014 - 2025 (USD Million) 8.3.1.4 Germany mycoplasma testing market, by end-use, 2014 - 2025 (USD Million) 8.3.2 UK 8.3.2.1 UK mycoplasma testing market, by product, 2014 - 2025 (USD Million) 8.3.2.2 UK mycoplasma testing market, by technology, 2014 - 2025 (USD Million) 8.3.2.3 UK mycoplasma testing market, by application, 2014 - 2025 (USD Million) 8.3.2.4 UK mycoplasma testing market, by end-use, 2014 - 2025 (USD Million) 8.4 Asia Pacific 8.4.1 Japan 8.4.1.1 Japan mycoplasma testing market, by product, 2014 - 2025 (USD Million) 8.4.1.2 Japan mycoplasma testing market, by technology, 2014 - 2025 (USD Million) 8.4.1.3 Japan mycoplasma testing market, by application, 2014 - 2025 (USD Million) 8.4.1.4 Japan mycoplasma testing market, by end-use, 2014 - 2025 (USD Million) 8.4.2 China 8.4.2.1 China mycoplasma testing market, by product, 2014 - 2025 (USD Million) 8.4.2.2 China mycoplasma testing market, by technology, 2014 - 2025 (USD Million) 8.4.2.3 China mycoplasma testing market, by application, 2014 - 2025 (USD Million) 8.4.2.4 China mycoplasma testing market, by end-use, 2014 - 2025 (USD Million) 8.4.3 India 8.4.3.1 India mycoplasma testing market, by product, 2014 - 2025 (USD Million) 8.4.3.2 India mycoplasma testing market, by technology, 2014 - 2025 (USD Million) 8.4.3.3 India mycoplasma testing market, by application, 2014 - 2025 (USD Million) 8.4.3.4 India mycoplasma testing market, by end-use, 2014 - 2025 (USD Million) 8.5 Latin America 8.5.1 Brazil 8.5.1.1 Brazil mycoplasma testing market, by product, 2014 - 2025 (USD Million) 8.5.1.2 Brazil mycoplasma testing market, by technology, 2014 - 2025 (USD Million) 8.5.1.3 Brazil mycoplasma testing market, by application, 2014 - 2025 (USD Million) 8.5.1.4 Brazil mycoplasma testing market, by end-use, 2014 - 2025 (USD Million) 8.5.2 Mexico Follow Us:

  8. 8.5.2.1 Mexico mycoplasma testing market, by product, 2014 - 2025 (USD Million) 8.5.2.2 Mexico mycoplasma testing market, by technology, 2014 - 2025 (USD Million) 8.5.2.3 Mexico mycoplasma testing market, by application, 2014 - 2025 (USD Million) 8.5.2.4 Mexico mycoplasma testing market, by end-use, 2014 - 2025 (USD Million) 8.6 MEA 8.6.1 South Africa 8.6.1.1 South Africa mycoplasma testing market, by product, 2014 - 2025 (USD Million) 8.6.1.2 South Africa mycoplasma testing market, by technology, 2014 - 2025 (USD Million) 8.6.1.3 South Africa mycoplasma testing market, by application, 2014 - 2025 (USD Million) 8.6.1.4 South Africa mycoplasma testing market, by end-use, 2014 - 2025 (USD Million) Chapter 9 Competitive Landscape 9.1 Company Profiles 9.1.1 Thermo Fisher Scientific, Inc. 9.1.1.1 Company overview 9.1.1.2 Financial performance 9.1.1.3 Product benchmarking 9.1.1.4 Strategic initiatives 9.1.2 Merck KGaA 9.1.2.1 Company overview 9.1.2.2 Financial performance 9.1.2.3 Product benchmarking 9.1.2.4 Strategic initiatives 9.1.3 Lonza Group Ltd. 9.1.3.1 Company overview 9.1.3.2 inancial performance 9.1.3.3 Product benchmarking 9.1.3.4 Strategic initiatives 9.1.4 Promo Cell GmbH 9.1.4.1 Company overview 9.1.4.2 Financial performance 9.1.4.3 Product benchmarking 9.1.4.4 Strategic initiatives 9.1.5 American Type Culture Collection 9.1.5.1 Company overview Follow Us:

  9. 9.1.5.2 Financial performance 9.1.5.3 Product benchmarking 9.1.5.4 Strategic initiatives 9.1.6 Charles River Laboratories International, Inc. 9.1.6.1 Company overview 9.1.6.2 Financial performance 9.1.6.3 Product benchmarking 9.1.6.4 Strategic initiatives 9.1.7 Bionique Testing Laboratories, Inc. 9.1.7.1 Company overview 9.1.7.2 Financial performance 9.1.7.3 Product benchmarking 9.1.7.4 Strategic initiatives 9.1.8 Biological Industries Israel Beit Haemek Ltd. 9.1.8.1 Company overview 9.1.8.2 inancial performance 9.1.8.3 Product benchmarking 9.1.8.4 Strategic initiatives 9.1.9 InvivoGen 9.1.9.1 Company overview 9.1.9.2 Financial performance 9.1.9.3 Product benchmarking 9.1.9.4 Strategic initiatives Follow Us:

  10. About Grand View Research, Inc.: Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy. Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415- 349-0058 Toll Free: 1-888- 202-9519 Email:sales@grandviewresearch.com For More Information:https://www.grandviewresearch.com Follow Us:

More Related